116 related articles for article (PubMed ID: 38385480)
1. Synthesis, in silico studies, and in vitro biological evaluation of newly-designed 5-amino-1
Nowdehi J; Mosaddegh E; Khaksar S; Torkzadeh-Mahani M; Beihaghi M; Yazdani M
J Biomol Struct Dyn; 2024 Feb; ():1-19. PubMed ID: 38385480
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
3. The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer.
Yu B; Gu D; Zhang X; Liu B; Xie J
J Genet Genomics; 2017 Aug; 44(8):375-383. PubMed ID: 28847472
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K
Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117
[TBL] [Abstract][Full Text] [Related]
5. In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer.
Perumalsamy H; Sankarapandian K; Veerappan K; Natarajan S; Kandaswamy N; Thangavelu L; Balusamy SR
Phytomedicine; 2018 Jul; 46():119-130. PubMed ID: 30097112
[TBL] [Abstract][Full Text] [Related]
6. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
[TBL] [Abstract][Full Text] [Related]
7. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.
Han JH; Kim M; Kim HJ; Jang SB; Bae SJ; Lee IK; Ryu D; Ha KT
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065602
[TBL] [Abstract][Full Text] [Related]
8. Supra-additive antitumor activity of 5FU with tumor necrosis factor-related apoptosis-inducing ligand on gastric and colon cancers in vitro.
Shimoyama S; Mochizuki Y; Kusada O; Kaminishi M
Int J Oncol; 2002 Sep; 21(3):643-8. PubMed ID: 12168112
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
Plasencia C; Abad A; Martinez-Balibrea E; Taron M
Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
[TBL] [Abstract][Full Text] [Related]
10. One-pot synthesis, computational chemical study, molecular docking, biological study, and in silico prediction ADME/pharmacokinetics properties of 5-substituted 1H-tetrazole derivatives.
El-Sewedy A; El-Bordany EA; Mahmoud NFH; Ali KA; Ramadan SK
Sci Rep; 2023 Oct; 13(1):17869. PubMed ID: 37857636
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
12. Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity.
Pavillard V; Formento P; Rostagno P; Formento JL; Fischel JL; Francoual M; Etienne MC; Milano G
Biochem Pharmacol; 1998 Nov; 56(10):1315-22. PubMed ID: 9825730
[TBL] [Abstract][Full Text] [Related]
13. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
Kim HJ; Han YS; Lee JH; Lee SH
Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
[TBL] [Abstract][Full Text] [Related]
14. G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Mirjolet JF; Didelot C; Barberi-Heyob M; Merlin JL
Cytometry; 2002 May; 48(1):6-13. PubMed ID: 12116375
[TBL] [Abstract][Full Text] [Related]
15. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
[TBL] [Abstract][Full Text] [Related]
16. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells.
Mori R; Yoshida K; Tanahashi T; Yawata K; Kato J; Okumura N; Tsutani Y; Okada M; Oue N; Yasui W
Gastric Cancer; 2013 Jul; 16(3):345-54. PubMed ID: 22968820
[TBL] [Abstract][Full Text] [Related]
17. New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole: synthesis and assessment of some biological activities.
de Oliveira LP; da Silva DP; Florentino IF; Fajemiroye JO; de Oliveira TS; Marcelino RI; Pazini F; Lião LM; Ghedini PC; de Moura SS; Valadares MC; de Carvalho VV; Vaz BG; Menegatti R; Costa EA
Chem Biol Drug Des; 2017 Jan; 89(1):124-135. PubMed ID: 27526659
[TBL] [Abstract][Full Text] [Related]
18. Metformin as an Alternative Radiosensitizing Agent to 5-Fluorouracil During Neoadjuvant Treatment for Rectal Cancer.
Fernandes JM; Jandrey EHF; Koyama FC; Leite KRM; Camargo AA; Costa ÉT; Perez RO; Asprino PF
Dis Colon Rectum; 2020 Jul; 63(7):918-926. PubMed ID: 32229782
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of poly(ethylene glycol)s linked to 5-fluorouracil via a urethane or urea bond.
Ouchi T; Hagihara Y; Takahashi K; Takano Y; Igarashi I
Drug Des Discov; 1992; 9(1):93-105. PubMed ID: 1457699
[TBL] [Abstract][Full Text] [Related]
20. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs.
Chanu KD; Thoithoisana S; Kar A; Mukherjee PK; Radhakrishnanand P; Parmar K; Sharma N
J Ethnopharmacol; 2024 Mar; 322():117591. PubMed ID: 38104872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
